Indication
Intrahepatic Bile Duct Cancer
1 clinical trial
2 products
1 drug
Clinical trial
Phase II Trial of Trifluridine/Tipiracil in Combination With Irinotecan in Biliary Tract CancersStatus: Completed, Estimated PCD: 2021-08-13
Drug
IrinotecanProduct
IrinotecanProduct
Trifluridine and Tipiracil